Stable and unstable amoxicillin resistance in Helicobacter pylori: should antibiotic resistance testing be performed prior to eradication therapy?
作者信息
Han S R, Bhakdi S, Maeurer M J, Schneider T, Gehring S
机构信息
Department of Medical Microbiology Johannes Gutenberg University Mainz, Germany.
出版信息
J Clin Microbiol. 1999 Aug;37(8):2740-1. doi: 10.1128/JCM.37.8.2740-2741.1999.
Abstract
摘要
相似文献
1
Stable and unstable amoxicillin resistance in Helicobacter pylori: should antibiotic resistance testing be performed prior to eradication therapy?幽门螺杆菌中阿莫西林耐药的稳定性与不稳定性：根除治疗前是否应进行抗生素耐药性检测？
J Clin Microbiol. 1999 Aug;37(8):2740-1. doi: 10.1128/JCM.37.8.2740-2741.1999.
2
[Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy].[幽门螺杆菌对阿莫西林和克拉霉素的敏感性及其在根除治疗中的特殊意义]
Kansenshogaku Zasshi. 1998 Apr;72(4):335-41. doi: 10.11150/kansenshogakuzasshi1970.72.335.
3
Amoxycillin resistance in an isolate of Helicobacter pylori from Melbourne.
Med J Aust. 2000 Nov 20;173(10):555.
4
[Antibiotic-resistant H. pylori strains in the last ten years in Japan].[日本过去十年中耐抗生素的幽门螺杆菌菌株]
Nihon Rinsho. 1999 Jan;57(1):81-6.
5
[Antimicrobial susceptibility tests and resistant strain of Helicobacter pylori].[幽门螺杆菌的药敏试验及耐药菌株]
Kansenshogaku Zasshi. 2003 Apr;77(4):187-94. doi: 10.11150/kansenshogakuzasshi1970.77.187.
6
Stable amoxicillin resistance in Helicobacter pylori.
Helicobacter. 2001 Mar;6(1):79. doi: 10.1046/j.1523-5378.2001.00002.x.
7
[Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].[儿童幽门螺杆菌感染首次治疗失败后获得性继发性耐药]
Arch Pediatr. 2002 Feb;9(2):130-5. doi: 10.1016/s0929-693x(01)00720-5.
8
Specific mutations of penicillin-binding protein 1A in 77 clinically acquired amoxicillin-resistant Helicobacter pylori strains in comparison with 77 amoxicillin-susceptible strains.77 株临床分离的耐阿莫西林幽门螺杆菌与 77 株阿莫西林敏感株青霉素结合蛋白 1A 特定突变的比较。
Helicobacter. 2017 Dec;22(6). doi: 10.1111/hel.12437. Epub 2017 Aug 25.
9
Amoxicillin for the treatment of Helicobacter pylori infection.
J Gastroenterol. 1996 Nov;31 Suppl 9:44-7.
10
Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018.韩国 2003 年至 2018 年幽门螺杆菌的初级和次级抗生素耐药性。
Helicobacter. 2019 Dec;24(6):e12660. doi: 10.1111/hel.12660. Epub 2019 Sep 11.
引用本文的文献
1
-Test or Agar Dilution for Metronidazole Susceptibility Testing of : Importance of the Prevalence of Metronidazole Resistance.用于甲硝唑敏感性测试的试验或琼脂稀释法：甲硝唑耐药性流行率的重要性
Front Microbiol. 2022 Mar 14;13:801537. doi: 10.3389/fmicb.2022.801537. eCollection 2022.
2
Genetic and Transcriptomic Variations for Amoxicillin Resistance in under Cryopreservation.冷冻保存条件下阿莫西林耐药性的遗传和转录组变异
Pathogens. 2021 May 30;10(6):676. doi: 10.3390/pathogens10060676.
3
E-test versus agar dilution for antibiotic susceptibility testing of Helicobacter pylori: a comparison study.E-test法与琼脂稀释法用于幽门螺杆菌抗生素敏感性检测的比较研究
BMC Res Notes. 2020 Jan 10;13(1):22. doi: 10.1186/s13104-019-4877-9.
4
Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection-A randomized controlled trial.序贯疗法与四联疗法作为幽门螺杆菌感染二线治疗的疗效和安全性——一项随机对照试验
PLoS One. 2017 Sep 28;12(9):e0183302. doi: 10.1371/journal.pone.0183302. eCollection 2017.
5
Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?超越马斯特里赫特IV标准：幽门螺杆菌的标准经验性三联疗法在一个南欧国家是否仍然有用？
BMC Gastroenterol. 2015 Feb 15;15:23. doi: 10.1186/s12876-015-0245-y.
6
Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients.从巴西南部患者分离出的幽门螺杆菌对阿莫西林、克拉霉素和环丙沙星的耐药性
Rev Inst Med Trop Sao Paulo. 2014 May-Jun;56(3):197-200. doi: 10.1590/s0036-46652014000300003.
7
Substitutions in penicillin-binding protein 1 in amoxicillin-resistant Helicobacter pylori strains isolated from Korean patients.从韩国患者中分离出的耐阿莫西林的幽门螺杆菌菌株中青霉素结合蛋白 1 的取代。
Gut Liver. 2013 Nov;7(6):655-60. doi: 10.5009/gnl.2013.7.6.655. Epub 2013 Aug 14.
8
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.体外研究 SQ109 对幽门螺杆菌的抗菌活性。
PLoS One. 2013 Jul 25;8(7):e68917. doi: 10.1371/journal.pone.0068917. Print 2013.
9
Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran.伊朗德黑兰消化不良患者分离的幽门螺杆菌的抗生素药敏谱。
Saudi J Gastroenterol. 2011 Jul-Aug;17(4):261-4. doi: 10.4103/1319-3767.82581.
10
In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection.新型抗菌剂TG44治疗幽门螺杆菌感染的体外活性
Antimicrob Agents Chemother. 2006 Sep;50(9):3062-9. doi: 10.1128/AAC.00036-06.
本文引用的文献
1
Stable amoxicillin resistance in Helicobacter pylori.幽门螺杆菌对阿莫西林的稳定耐药性。
Lancet. 1998 Nov 14;352(9140):1595. doi: 10.1016/s0140-6736(98)00064-6.
2
Evidence for a conjugation-like mechanism of DNA transfer in Helicobacter pylori.幽门螺杆菌中DNA转移的类接合机制的证据。
J Bacteriol. 1998 Jun;180(11):2901-5. doi: 10.1128/JB.180.11.2901-2905.1998.
3
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.幽门螺杆菌对阿莫西林、克拉霉素和甲硝唑产生体外耐药性的风险。
Antimicrob Agents Chemother. 1998 May;42(5):1222-8. doi: 10.1128/AAC.42.5.1222.
4
Optimized BlaM-transposon shuttle mutagenesis of Helicobacter pylori allows the identification of novel genetic loci involved in bacterial virulence.幽门螺杆菌的优化BlaM转座子穿梭诱变技术可鉴定出参与细菌毒力的新基因位点。
Mol Microbiol. 1996 Apr;20(2):361-73. doi: 10.1111/j.1365-2958.1996.tb02623.x.
Zotero 插件